Advertisement
Screener

INHIBRX BIOSCIENCES, INC. (INBX) Market Cap

INHIBRX BIOSCIENCES, INC. (INBX) Market Cap

  • 2026-09-03: Market Cap $1.79B.
  • 2026-08-07: Market Cap $1.3B.
  • 2026-06-30: Market Cap $1.39B.
  • 2026-05-08: Market Cap $1.97B.

Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.

Available history
2024-05-29 to 2026-09-03
Data captured

Historical Market Cap

DateMarket Cap
2026-09-03$1.79B
2026-08-07$1.3B
2026-06-30$1.39B
2026-05-08$1.97B
2026-03-31$982.05M
2026-03-11$1.07B
2025-12-31$1.15B
2025-11-07$1.17B
2025-09-30$488.3M
2025-08-08$305.06M
2025-06-30$206.57M
2025-05-09$161.77M
2025-03-31$202.52M
2025-02-28$191.81M
2024-12-31$222.93M
2024-11-08$234.65M
2024-09-30$226.69M
2024-08-09$159.81M
2024-06-30$205.12M
2024-05-29$181.05M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
Immunocore Holdings plc (IMCR)$1.613B-90.43
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
NOVAVAX INC (NVAX)United States$1.748B-6.26
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Vor Biopharma Inc. (VOR)United States$1.091B1.60
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81